{"id":"https://genegraph.clinicalgenome.org/r/6f59b04e-2bf5-4cdb-b766-c651522ff030v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between UQCRQ and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of October 14, 2019. A single homozygous variant in UQCRQ has been reported in humans with Leigh syndrome spectrum in a single publication in 2008 (PMID: 18439546). The homozygous variant reported in this publication (PMID: 18439546) demonstrated complete penetrance in more than 20 affected individuals in a large consanguineous Israeli Bedouin kindred. Evidence supporting the gene-disease relationship between UQCRQ and Leigh syndrome spectrum includes case-level data of one proband and segregation data from the 2008 study. This gene-disease association is further supported by UQCRQ protein expression in brain. As there is currently only one publication demonstrating UQCRQâ€™s role in human disease, there is limited evidence to support the relationship between UQCRQ and autosomal recessive Leigh syndrome spectrum. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on October 14, 2019 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/6f59b04e-2bf5-4cdb-b766-c651522ff030","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2019-10-16T14:46:56.909Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39ae2ff7-d9f4-46ad-84e7-5f27031abce6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Three-dimensional modeling of the Bovine Mitochondrial bc1 Complex17 (which contains the UQCRQ homolog) suggests that the Ser45 lies at a critical hinge position likely determining the orientation of the extramembrane domain of the molecule.18 Thus, we assume that an amino acid that is significantly structurally different at this position alters the orientation of this extramembrane domain.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06a043f6-bc8d-49bf-b085-08f99953f8b7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18439546","rdfs:label":"Pedigree C Individual 133","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"sequence analysis  of UQCRQ revealedac.208C/ Tmutation in exon 2, replacing serine at position 45 by phenylalanine (p.Ser45Phe) in the encoded protein, UQCRQ , complex III subunit VII, 9.5 kDa.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Brain MRI consistent with a diagnosis of Leigh syndrome. Bilateral symmetrical abnormal findings in the basal ganglia, with increased density in the putamen and decreased density and size of the caudate and globus pallidum nuclei.","previousTesting":true,"previousTestingDescription":"genome-wide linkage analysis with 400 fluorescent end-labeled polymor-phic markers (ABI PRISM Linkage Mapping Set MD10[Applied Biosystems]) as previously described.14 Noninfor-mative regions were excluded with additional adjacent microsatellite markers (data not shown). We identified only a single locus in which most affected individuals demonstrated increased homozygosity, whereas all obliga-tory carriers tested were shown to be heterozygous (data not shown). The locus, spanning approximately 9 cM (cor-responding to 15.84 Mb) on chromosome 5q31, resides between marker D5S471 (homozygosity in five of seven affected individuals) and D5S2115 (homozygosity in eight of 11 affected individuals). Sequencing of the coding regions of all 30 genes within the 5q31 locus (other thanUQCRQ ) revealed no mutations","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/39ae2ff7-d9f4-46ad-84e7-5f27031abce6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18439546","allele":{"id":"https://genegraph.clinicalgenome.org/r/9bec24d5-d1f1-4856-abeb-28edf06998ee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014402.5(UQCRQ):c.134C>T (p.Ser45Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/729"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75d3ea50-667b-4305-a124-6fa9901ae081_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18439546","rdfs:label":"Barel et al 2008","family":{"id":"https://genegraph.clinicalgenome.org/r/75d3ea50-667b-4305-a124-6fa9901ae081","type":"Family","rdfs:label":"Barel et al 2008","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/06a043f6-bc8d-49bf-b085-08f99953f8b7"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Brain magnetic resonance imaging (MRI) done in five affected patients showed bilateral symmetric abnormal findings in the basal ganglia. The MRI of Patient 133 (Kindred C) demonstrated bilateral symmetrical abnormal findings in the basal ganglia, with increased density in the putamen and decreased density and size of the caudate and globus","phenotypeNegativeAlleleNegative":47,"phenotypePositiveAllelePositive":20,"phenotypes":["obo:HP_0003128","obo:HP_0012736"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/06a043f6-bc8d-49bf-b085-08f99953f8b7"},"publishedLodScore":8.82,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b71dfa1a-b3ae-4bb9-aff2-a227b172c0f3","type":"EvidenceLine","dc:description":"Evidence showing that protein expression is disrupted in any tissue or cell type and/or evidence expression in the brain. (Awarded 0.5 pts)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9cc41a63-37db-4efc-b01a-d65858abaa38","type":"Finding","dc:description":"The Human Protein Atlas Atlas demonstrates that UQCRQ protein is expressed in most tissues (https://www.proteinatlas.org/ENSG00000164405-UQCRQ/tissue) Expression in the brain has been shown in the cerebral cortex, basal ganglia, and cerebellum. Points can be awarded as this expression profile is consistent with areas of pathology in Leigh-like syndrome","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25613900","rdfs:label":"UQCRQ Human Protein Atas Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Limited","sequence":93,"specifiedBy":"GeneValidityCriteria6","strengthScore":4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/X9b83P8w03k","type":"GeneValidityProposition","disease":"obo:MONDO_0009723","gene":"hgnc:29594","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9bf205a2-6eb3-40aa-b3dd-54c19ce6e6f7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}